Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase II Double-blind, RandomizEd, Prospective, Placebo Controlled STudy of NanO2TM Combined with Radiation and Temozolomide in Patients with Newly-diagnosed Glioblastoma MultiformE:
Sponsored by Nuvox Pharma, LLC
Active
$413.4K Funding
3 People
External
Related Topics
oxygen therapy,
glioblastoma,
radiation therapy,
temozolomide,
clinical trial
People
Angelica Erunez
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Shona Dougherty
Co-Investigator (COI)
College of Medicine - Tucson
﹒Professor
Baldassarre Stea
Principal Investigator (PI)
College of Medicine - Tucson
﹒Department Head
